salicylamides - CISMeF

Preferred Label : salicylamides;

MeSH definition : Amides of salicylic acid.;

Wikipedia link : https://en.wikipedia.org/wiki/Salicylamides;

Codes EINECS : 200-609-3;

Is substance : O;

Details

Origin ID

D012457;

UMLS CUI

C0036072;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Record concept(s)
- salicylamides [MeSH concept]
Related MeSH Supplementary Concept(s)
- 2,3-cresotamide [MeSH Supplementary Concept]
- 2-hydroxybenzoyl-N-(5-chlorothiazol-2-yl)amide [MeSH Supplementary Concept]
- 3-iodo-4-azido-N-hexadecylsalicylamide [MeSH Supplementary Concept]
- 3-nitro-N-methyl-salicylamide [MeSH Supplementary Concept]
- 4-fluoroeticlopride [MeSH Supplementary Concept]
- 5-(2-(2,5-dimethoxyphenyl)acetyl)-N-((4-fluorophenyl)ethyl)salicylamide [MeSH Supplementary Concept]
- 5-(2-(2,5-dimethoxyphenyl)ethyl)-N-((4-fluorophenyl)ethyl)salicylamide [MeSH Supplementary Concept]
- 5-(3-(4-azido-3,5-diiodosalicylamido)-1-propenyl)-uridine diphosphate N-acetylglucosamine [MeSH Supplementary Concept]
- 5-(3-(4-azido-3,5-diiodosalicylamido-)-1-propenyl)-uridine diphosphate N-acetylgalactosamine [MeSH Supplementary Concept]
- ACD 15 [MeSH Supplementary Concept]
- ACD 16 [MeSH Supplementary Concept]
- FLA 797 [MeSH Supplementary Concept]
- FLB 457 [MeSH Supplementary Concept]
- FLB 463 [MeSH Supplementary Concept]
- JBIR-58 [MeSH Supplementary Concept]
- N'-(2,4-dihydroxybenzylidene)-2-hydroxybenzohydrazide [MeSH Supplementary Concept]
- N'-(2-hydroxy-3-methoxybenzylidene)-2-hydroxybenzoylhydrazone [MeSH Supplementary Concept]
- N,N'-bis(salicyl)hydrazine [MeSH Supplementary Concept]
- N-(3-chloro-4-fluorophenyl)-2-hydroxy-4-(3-morpholinopropoxy)benzamide [MeSH Supplementary Concept]
- N-(4-methylphenyl)-3,5-dibromosalicylamide [MeSH Supplementary Concept]
- N-methacryloylamidoethyl 5-aminosalicylamide [MeSH Supplementary Concept]
- N-salicyloyl-N'-(4-hydroxybenzthioyl)hydrazine [MeSH Supplementary Concept]
- NCQ 298 [MeSH Supplementary Concept]
- O-acetylsalicylhydroxamic acid [MeSH Supplementary Concept]
- O-benzyl salicylamide [MeSH Supplementary Concept]
- Octadon-N [MeSH Supplementary Concept]
- SC21 compound [MeSH Supplementary Concept]
- arylid [MeSH Supplementary Concept]
- aspirin, caffeine, salicylamide drug combination [MeSH Supplementary Concept]
- benzyl pyridine-3-carboxylate, camphor, capsici extract, diethylammonium salicylate, dolo visano, salicylamide drug combination. [MeSH Supplementary Concept]
- beta-salicyloylamino-alpha-exo-methylene-gamma-butyrolactone [MeSH Supplementary Concept]
- bucetin, caffeine, dibenzoylthiamine, ethenzamide drug combination [MeSH Supplementary Concept]
- buclosamide [MeSH Supplementary Concept]
- compound 78-265 [MeSH Supplementary Concept]
- desmethoxyfallypride [MeSH Supplementary Concept]
- edasalonexent [MeSH Supplementary Concept]
- efuamide [MeSH Supplementary Concept]
- ethenzamide [MeSH Supplementary Concept]
- eticlopride [MeSH Supplementary Concept]
- fluororaclopride [MeSH Supplementary Concept]
- methyl 3-(5-(4-(3,5-dimethoxyphenyl)-1H-1,2,3-triazol-1-yl)-2-hydroxybenzamido)benzoate [MeSH Supplementary Concept]
- percutalgine [MeSH Supplementary Concept]
- promysalin [MeSH Supplementary Concept]
- salicylamide [MeSH Supplementary Concept]
- salicylamide glucuronide [MeSH Supplementary Concept]
- salicylamide-2-acetic acid [MeSH Supplementary Concept]
- salicylhydroxamic acid [MeSH Supplementary Concept]
- spalt-tablette [MeSH Supplementary Concept]
- triacetylsalicylhydroxamic acid [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
Validated automatic mappings to BTNT
- Salicylamide [ICD-11 Extension code]
- Salicylamide [LOINC component]
- Salicylamide [NCIt concept]
- Salicylamide (substance) [SNOMED CT concept]
- salicylamide [ATC Code]
- salicylamide [SNOMED Notion]
- salicylamide [Substance BNPC]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients